Literature DB >> 32067815

Hormone therapy (HT) in women with gynecologic cancers and in women at high risk for developing a gynecologic cancer: A Society of Gynecologic Oncology (SGO) clinical practice statement: This practice statement has been endorsed by The North American Menopause Society.

A K Sinno1, J Pinkerton2, T Febbraro3, N Jones4, N Khanna5, S Temkin6, D Iglesias7, B Pothuri8.   

Abstract

Entities:  

Year:  2020        PMID： 32067815     DOI： 10.1016/j.ygyno.2020.01.035

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  4 in total

1.  Barriers to surgical menopause counseling in gynecologic cancers: a quantitative and qualitative study of patients and providers.

Authors:  Connor C Wang; Dandi S Huang; Anisa M Carlson; Zhanhai Li; Ahmed Al-Niaimi; Makeba Williams
Journal:  Menopause       Date:  2022-08-01       Impact factor: 3.310

2.  Pilot study of fractional CO2 laser therapy for genitourinary syndrome of menopause in gynecologic cancer survivors.

Authors:  Allison M Quick; Travis Dockter; Jennifer Le-Rademacher; Ritu Salani; Catherine Hudson; Andrew Hundley; Shelby Terstriep; Lauren Streicher; Stephanie Faubion; Charles L Loprinzi; Jenell S Coleman; Karen C Wang; Maryam Lustberg
Journal:  Maturitas       Date:  2020-12-02       Impact factor: 4.342

Review 3.  Risk-Reducing Bilateral Salpingo-Oophorectomy for Ovarian Cancer: A Review and Clinical Guide for Hereditary Predisposition Genes.

Authors:  Ying L Liu; Kelsey Breen; Amanda Catchings; Megha Ranganathan; Alicia Latham; Deborah J Goldfrank; Rachel N Grisham; Kara Long Roche; Melissa K Frey; Dennis S Chi; Nadeem Abu-Rustum; Carol Aghajanian; Kenneth Offit; Zsofia K Stadler
Journal:  JCO Oncol Pract       Date:  2021-09-28

4.  Pelvic seromucinous borderline tumor 26 years after ovarian seromucinous borderline tumor managed with post-treatment estrogen replacement therapy.

Authors:  Takashi Uehara; Hiroshi Yoshida; Tomoyasu Kato
Journal:  Gynecol Oncol Rep       Date:  2020-12-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.